Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: Mark Fowler who wrote (126372)	6/11/2001 4:45:34 PM
From: craig crawford	Respond to of 164684

4:30pm 06/11/01 Affymetrix sees revs below Street view (AFFX) By Alexander Davis Affymetrix, which makes systems for biotechnology research, warned Monday that it will post lower-than-expected second-quarter revenue as low as $44 million, below most analyst estimates. It now expects a loss of $4 million to $7 million, excluding noncash and acquisition-related charges. The company said the revenue shortfall reflects lower orders for its GeneChip product and a decline in the market for spotted array instruments. Ahead of the news, which was announced after the closing bell, shares of Affymetrix (AFFX) closed down $3.76, or 8.4 percent, at $40.95.